Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Functional evidence for the existence of ETA-ETB receptor crosstalk in the heart.
Publication

Publications

Functional evidence for the existence of ETA-ETB receptor crosstalk in the heart.

Title
Functional evidence for the existence of ETA-ETB receptor crosstalk in the heart.
Type
Summary of Presentation in an International Conference
Year
2007
Authors
Brás-Silva C
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Monteiro-Sousa D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Duarte AJ
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Leite-Moreira AF
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Conference proceedings International
Pages: 145-146
Heart Failure 2007
Hamburgo, Alemanha, 09 a 12 de Junho de 2007
Scientific classification
FOS: Medical and Health sciences > Other medical sciences
Other information
Resumo (PT): Endothelin (ET)-1 acts on ETA and ETB receptors. While the former increase inotropy, the latter can be subdivided in endothelial ETB1, which decrease inotropy, and myocardial ETB2, which increase inotropy. This study investigated, in rabbit papillary muscles, functional evidences of the existence of ETA-ETB receptor crosstalk in the heart. ET-1 (0.1- 10nM) was given in the presence of: (i) intact endocardial endothelium (EE, n=9); (ii) damaged EE (n=8); (iii) intact EE and BQ-123 (ETA antagonist, n=8); (iv) intact EE and BQ-788 (ETB2 antagonist, n=8); (v) intact EE and both BQ-788 and RES-701-1 (ETB1 antagonist, n=8); (vi) damaged EE and BQ-123 (n=8); (vii) damaged EE and BQ-788 (n=7). The effects of Sarafotoxin S6c (ETB agonist, 0.1nM-1μM) were evaluated in muscles with: (i) intact EE and in the presence (n=8) and in the absence (n=7) of BQ-123 and (ii) damaged EE and in the presence (n=9) and in the absence (n=7) of BQ-123.ET-1 alone elicited positive inotropic effects that were potentiated by concomitant inhibition of endothelial and myocardial ETB receptors. In muscles with damaged EE, ET-1 increased inotropy when ETA receptors were blocked, indicating that ETB2 receptors elicited a positive inotropic effect which could not be observed when EE was intact and ETB1 functional. Additionally, the negative inotropic effect induced by selective ETB activation was enhanced by ETA antagonism in the presence of an intact EE. On the other hand, the positive inotropic effect elicited by ETB stimulation in the absence of EE required the presence of active ETA. These results reveal that ET-1 activity is likely to depend on a complex balance of ETA- and ETB-mediated effects with factors such as functional endothelial integrity and efficiency of receptor subtype or receptor-effector coupling determining the overall response. These findings might help to improve our understanding about the role of ET-1 in the intrinsic modulation of cardiac function, and should be taken into account in the therapeutic studies using selective ETA or mixed ETA/ETB receptor antagonists.
Language: English
Type (Professor's evaluation): Scientific
Notes: Heart Failure 2007, published in journal, European Journal of Heart Failure. 2007; 6(Suppl.1):145-146.
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

O aumento da distensibilidade miocárdica induzido pela endotelina-1 depende da libertação endotelial de NO e prostaglandinas. (2006)
Summary of Presentation in a National Conference
Brás-Silva C; Monteiro-Sousa D; Duarte AJ; Fontes-Sousa AP; Leite-Moreira AF
Atenuação da resposta miocárdica à endotelina-1 e à angiotensina II com evidência de disfunção endotelial endocárdica na insuficiência cardíaca. (2006)
Summary of Presentation in a National Conference
Brás-Silva C; Castro-Chaves P; Fontes-Sousa AP; Pimentel-Nunes P; Monteiro-Sousa D; Duarte AJ; Leite-Moreira AF
Urocortin 2 as a novel neurohumoralmodulator of diastolic function. (2007)
Summary of Presentation in an International Conference
Brás-Silva C; Monteiro-Sousa D; Duarte AJ; Leite-Moreira AF
Urocortin 2 acutely increases diastolic distensibility. (2007)
Summary of Presentation in an International Conference
Brás-Silva C; Monteiro-Sousa D; Duarte AJ; Leite-Moreira AF
Urocortin 2 acutely decreases myocardial stiffness. (2007)
Summary of Presentation in an International Conference
Brás-Silva C; Duarte AJ; Monteiro-Sousa D; Leite-Moreira AF

See all (8)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-20 at 04:13:47 | Privacy Policy | Personal Data Protection Policy | Whistleblowing